1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Preclinical Studies with 15-Deoxyspergualin in Various Animal Models for Autoimmune Diseases

      ,
      Annals of the New York Academy of Sciences
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Autoimmunity to type II collagen an experimental model of arthritis

          We have found that intradermal injection of native type II collagen extracted from human, chick or rat cartilage induces an inflammatory arthritis in approximately 40% of rats of several strains whether complete Freund's adjuvant or incomplete Freund's adjuvant is used. Type I or III collagen extracted from skin, cartilage proteoglycans and alpha1(II) chains were incapable of eliciting arthritis, as was type II collagen injected without adjuvant. The disease is a chronic proliferative synovitis, resembling adjuvant arthritis in rats and rheumatoid arthritis in humans. Native type II co-lagen modified by limited pepsin digestion still produces arthritis, suggesting that type- specific determinants residing in the helical region of the molecule are responsible for the induction of disease. Since homologous type II collagen emulsified in oil without bacterial preparations regularly causes the disease, this new animal model of arthritis represents a unique example of experimentally-inducible autoimmunity to a tissue component.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Immunisation against heterologous type II collagen induces arthritis in mice.

            The induction of polyarthritis in rats by intradermal immunisation with homologous or heterologous type II collagen incomplete or incomplete Freund's adjuvant was reported recently by Trentham et al. We have now produced a similar disease in certain strains of mice.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

              Almost 50% of the cells infiltrating the central nervous system (CNS) of animals with experimental allergic encephalomyelitis (EAE) are macrophages (M psi). To investigate the role of the M psi in the pathogenesis of EAE, we eliminated M psi by means of mannosylated liposomes containing dichloromethylene diphosphonate (Cl2MDP). Cl2MDP- containing liposomes injected intravenously eliminate M psi in spleen and liver. Incorporation of mannose into the lipid layers enables the liposomes to pass the blood-brain barrier (BBB). Injections of Cl2MDP- containing mannose liposomes intravenously shortly before the appearance of clinical signs, markedly suppressed the expression of clinical signs of EAE. This suppression was accompanied by a marked reduction of infiltrated M psi in the CNS. Cl2MDP-containing liposomes without mannose incorporated had no effect. Cl2MDP-containing mannosylated liposomes had no effect on plasma corticosterone levels compared with injections of saline; thus, the suppression of expression of EAE was not corticosterone mediated. These results show that the M psi within the CNS play an important role in the pathogenesis of EAE.
                Bookmark

                Author and article information

                Journal
                Annals of the New York Academy of Sciences
                Ann NY Acad Sci
                Wiley
                0077-8923
                1749-6632
                June 1993
                June 1993
                : 685
                : 1 Immunomodulat
                : 155-174
                Article
                10.1111/j.1749-6632.1993.tb35862.x
                b5807bc2-c9e5-47d2-bc74-1d70c46862ad
                © 1993

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article